Esthesioneuroblastoma CT

Esthesioneuroblastoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Esthesioneuroblastoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Esthesioneuroblastoma CT On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Esthesioneuroblastoma CT All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Esthesioneuroblastoma CT
CDC on Esthesioneuroblastoma CT
Esthesioneuroblastoma CT in the news
Blogs on Esthesioneuroblastoma CT
Directions to Hospitals Treating Esthesioneuroblastoma
Risk calculators and risk factors for Esthesioneuroblastoma CT

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]

CT

CT is particularly useful in assessing bony destruction, although it cannot distinguish olfactory neuroblastomas from other tumors that arise in the same region. The mass is of soft tissue attenuation, with relatively homogeneous enhancement 3. Focal calcification are occasionally present 3. These tumors are relatively slow growing and thus, the bony margins are often remodeled and resorbed, rather than being aggressively destroyed